We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchiasis

By LabMedica International staff writers
Posted on 19 Aug 2015
Opisthorchis viverrini is distinct among helminth infections as it drives a chronic inflammatory response in the intrahepatic bile duct that progresses from advanced periductal fibrosis (APF) to cholangiocarcinoma (CCA).

Oxidative stress (OS) plays a critical role in the transition from chronic O. More...
viverrini infection to CCA and also results in the excision of a modified DNA lesion 8-oxodG into urine, the levels of which can be detected by immunoassay.

Scientists at Khon Kaen University (Thailand) and an international team of collaborators, assigned 149 individuals to three groups; Group 1 were 23 individuals negative (uninfected) upon fecal examination for O. viverrini; Group 2 were 48 O. viverrini positive (OV+) individuals who were negative for APF; and Group 3 were 78 O. viverrini positive individuals who were also positive for APF. Group 4 consists of samples from 33 individuals who had histologically proven O. viverrini-associated CCA, whose urine samples had been stored.

Venous blood samples were collected from individuals in Groups 1, 2 and 3, into siliconized tubes after overnight fasting. Venous blood samples were allowed to clot at room temperature for 30 minutes after collection, centrifuged, and the serum recovered. An enzyme-linked immunosorbent assay (ELISA) was used to quantify levels of the antibody against O. viverrini antigen in serum. Concentration of 8-oxodG in urine was measured using a validated competitive ELISA kit (HT Trevigen, Gaithersburg, MD, USA). The ELISA plates were read using a SpectraMax 340PC384 microplate reader (Molecular Devices, Sunnydale, CA, USA).

Elevated concentrations of 8-oxodG in urine was positively associated with APF and CCA in a strongly dose-dependent manner. Urinary 8-oxodG concentrations also accurately predicted whether an individual presented with APF or CCA compared to O. viverrini infected individuals without these pathologies. Urinary 8-oxodG is a robust candidate biomarker of the progression of APF and CCA from chronic opisthorchiasis, which is indicative of the critical role that OS plays in both of these advanced hepatobiliary pathologies.

The authors confirmed their previous observations that severe liver pathology occurs early and asymptomatically in residents of O. viverrini endemic regions, where individuals are infected for years and often decades with this food-borne pathogen. These findings also contribute to an expanding literature on 8-oxodG in an easily accessible bodily fluid as in urine, as a biomarker in the multistage process of inflammation, fibrogenesis, and infection-induced cancer. O. viverrini is commonly known as the Southeast Asian liver fluke. The study was published on July 31, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Khon Kaen University 
HT Trevigen 
Molecular Devices 



Gold Member
Serological Pipets
INTEGRA Serological Pipets
Portable Electronic Pipette
Mini 96
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.